Background and Aims Barrett's esophagus with low-grade dysplasia (BE-LGD) carries a risk
of progression to Barrett's esophagus with high-grade dysplasia (BE-HGD) and esophageal …

Background: Endoscopic therapy using radiofrequency ablation (RFA) is a recommended
treatment for Barrett's esophagus with high-grade dysplasia (BE-HGD) without a visible …

Background Barrett's esophagus (BE) is a premalignant condition characterized by
replacement of the esophageal lining with metastatic columnar epithelium, and its …

Background and Aims A prior randomized study (Surveillance versus Radiofrequency
Ablation study [SURF study]) demonstrated that radiofrequency ablation (RFA) of Barrett's …

Objectives: Barrett's esophagus (BE) is the only identifiable premalignant condition for
esophageal adenocarcinoma (EAC). Management of BE with low-grade dysplasia continues …

Background & Aims Barrett's esophagus (BE) with low-grade dysplasia (LGD) can progress
to high-grade dysplasia (HGD) and esophageal adenocarcinoma (EAC). Radiofrequency …

Background and objective: Barrett's esophagus (BE) is associated with an increased risk of
esophageal adenocarcinoma. The use of radio frequency ablation (RFA) for complete …

Background & Aims In patients with Barrett's esophagus (BE), radiofrequency ablation (RFA)
safely and effectively eradicates dysplasia and intestinal metaplasia. We aimed to determine …

Background Barrett's esophagus (BE) serves as a premalignant marker for the development
of esophageal adenocarcinoma (EAC). While this progression is known to involve the …

Background: Low-grade dysplasia (LGD) in Barrett's esophagus (BE) is associated with an
increased risk of progression to high-grade dysplasia (HGD) and/or esophageal …